This statistic shows the operating expenses of Danish biotechnology company Genmab from 2017 to 2023. From 2017 onwards the company reported increasing operating expenses. The amount peaked in 2023, at around 11 billion Danish kroner. Genmab is a Danish biotechnology company founded in 1999. The company is specializing in therapeutics for cancer treatment.
Operating expenses of Genmab from 2017 to 2023
(in million DKK)
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Genmab. (March 4, 2024). Operating expenses of Genmab from 2017 to 2023 (in million DKK) [Graph]. In Statista. Retrieved July 23, 2024, from https://www.statista.com/statistics/970445/operating-expenses-of-genmab/
Genmab. "Operating expenses of Genmab from 2017 to 2023 (in million DKK) ." Chart. March 4, 2024. Statista. Accessed July 23, 2024. https://www.statista.com/statistics/970445/operating-expenses-of-genmab/
Genmab. (2024). Operating expenses of Genmab from 2017 to 2023 (in million DKK) . Statista. Statista Inc.. Accessed: July 23, 2024. https://www.statista.com/statistics/970445/operating-expenses-of-genmab/
Genmab. "Operating Expenses of Genmab from 2017 to 2023 (in Million Dkk) ." Statista, Statista Inc., 4 Mar 2024, https://www.statista.com/statistics/970445/operating-expenses-of-genmab/
Genmab, Operating expenses of Genmab from 2017 to 2023 (in million DKK) Statista, https://www.statista.com/statistics/970445/operating-expenses-of-genmab/ (last visited July 23, 2024)
Operating expenses of Genmab from 2017 to 2023 (in million DKK) [Graph], Genmab, March 4, 2024. [Online]. Available: https://www.statista.com/statistics/970445/operating-expenses-of-genmab/